Clinical experience with cell salvage in obstetrics: 4 cases from one UK centre

Catling, S.; Freites, O.; Krishnan, S.; Gibbs, Ronald S.

doi:10.1054/ijoa.2001.0914

Cited by 35 publications

(30 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other reported complications include: operator error using the cell saver; 11 heparin toxicity 34 and coagulopathy. 20,35 There is a need to generate reliable safety data for IOCS in obstetrics.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Cell salvage at caesarean section: the need for an evidence‐based approach

Geoghegan

Daniels

Moore

et al. 2009

BJOG

View full text Add to dashboard Cite

Haemorrhage, a leading cause of maternal morbidity and mortality, is frequently associated with caesarean section. Allogeneic blood is an increasingly rare and scare resource. Intraoperative Cell Salvage (IOCS) offers the possibility of improving outcome and reducing allogeneic blood transfusion in cases of haemorrhage at caesarean section. The available literature on the use of IOCS in obstetrics demonstrates that there is limited evidence to support or refute the use of IOCS at caesarean section. However, this procedure has been introduced into obstetric practice. Before opinions about its use become solidified, there is a window of opportunity to launch a large multicentre randomised controlled trial to address the current equipoise.

show abstract

Section: Resultsmentioning

confidence: 99%

“…29 More recently, cell salvage has been increasingly used in obstetric practice, mainly at caesarean section, 11,20,[30][31][32][33][34][35][36][37][38][39][40][41] but what is the evidence for its use? Unfortunately the quality and quantity of available data to inform the decision making processes are poor.…”

Section: Introductionmentioning

confidence: 99%

Cell salvage at caesarean section: the need for an evidence‐based approach

Geoghegan

Daniels

Moore

et al. 2009

BJOG

View full text Add to dashboard Cite

show abstract

“…Furthermore, the control group transfusion rate of 23.5% was at least four times greater than normal practice in the UK. The methodology employed in other studies, including a retrospective review, 45 case series and isolated case reports, [46][47][48][49][50][51][52][53][54] precluded definitive conclusions but supported the safety of cell salvage in obstetrics.…”

Section: Existing Evidencementioning

confidence: 99%

A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial

Khan

Moore

Wilson

et al. 2018

Health Technol Assess

View full text Add to dashboard Cite

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/).Editorial contact: journals.library@nihr.ac.ukThe full HTA archive is freely available to view online at www.journalslibrary.nihr.ac.uk/hta. Print-on-demand copies can be purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk Criteria for inclusion in the Health Technology Assessment journalReports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. HTA programmeThe HTA programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform National Institute for Health and Care Excellence (NICE) guidance. HTA research is also an important source of evidence for National Screening Committee (NSC) policy decisions.For more information about the HTA programme please visit the website: http://www.nets.nihr.ac.uk/programmes/hta This reportThe research reported in this issue of the journal was funded by the HTA programme as project number 10/57/32. The contractual start date was in October 2012. The draft report began editorial review in December 2016 and was accepted for publication in March 2017. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health. Published by t...

show abstract

“…The literature mostly comprises small series, retrospective studies, case reports and correspondence, with only one small reported controlled, prospective trial. The available information encompasses its use in elective and emergency caesarean section, 60,73,87,88 placenta praevia, 89,90 Jehovah's Witnesses, 26,91,92 and laparotomy for postpartum haemorrhage. 26,93 Both early and more recent reports of blood salvage and autotransfusion during caesarean section have been encouraging and deemed safe, although details are often incomplete.…”

Section: Clinical Evidencementioning

confidence: 99%

“…26 Indeed, the Obstetric Anaesthetist's Association/Association of Anaesthetists of Great Britain and Ireland (OAA/ AAGBI) Guidelines for Obstetric Anaesthetic Services published in 2005, 27 state ''an increasing shortage of blood and blood products, and growing anxiety about the use of donor blood, is leading to an increasing interest in the use of cell salvage in obstetrics''. We reviewed the medical literature to ascertain the principles, efficacy and safety of cell salvage in the obstetric setting.…”

Section: Introductionmentioning

confidence: 99%